Medfinder
Back to blog

Updated: April 2, 2026

How Does YF-Vax Work? Mechanism of Action Explained in Plain English

Author

Peter Daggett

Peter Daggett

YF-Vax blog header image

YF-Vax is a live-attenuated vaccine that teaches your immune system to fight yellow fever. Here's how it works — and why a single dose protects most people for life.

YF-Vax is one of the most effective vaccines ever developed — a single dose protects most healthy people for life. But how does it actually work? Understanding the science behind YF-Vax can help you feel more confident about getting vaccinated and explain why it works so well (and why certain groups need to be more cautious).

What Is Yellow Fever?

Yellow fever is caused by the yellow fever virus (YFV), a single-stranded RNA virus belonging to the genus Flavivirus — the same family as dengue, Zika, and West Nile virus. It is transmitted to humans through the bite of an infected Aedes or Haemagogus mosquito in tropical and subtropical regions of Africa and South America.

Most infections are asymptomatic or cause only mild illness. But in severe cases, yellow fever causes liver failure (leading to jaundice — the "yellow" in the name), kidney failure, hemorrhagic bleeding, and shock. The case-fatality rate in severe yellow fever is typically 20% or higher. There is no specific antiviral treatment; prevention through vaccination is the primary defense.

What Is a Live-Attenuated Vaccine?

YF-Vax is a

live-attenuated vaccine — meaning it contains a real, living version of the yellow fever virus that has been deliberately weakened ("attenuated") so it cannot cause disease in healthy people, but can still trigger a robust immune response.

This is different from inactivated vaccines (like flu shots, which use killed virus) or subunit vaccines (like hepatitis B, which use only a protein piece of the virus). Live-attenuated vaccines generally produce stronger, longer-lasting immunity because the immune system experiences something much closer to a real infection.

The 17D Strain: Over 80 Years of Protection

YF-Vax uses the 17D-204 strain of the yellow fever virus, derived from the original 17D strain developed in the 1930s by Max Theiler and colleagues at the Rockefeller Foundation. Theiler passed the virulent Asibi strain of yellow fever through hundreds of generations of mouse brains and chicken embryos, progressively weakening it until it could no longer cause serious disease in primates — while still generating strong immunity.

Max Theiler received the Nobel Prize in Physiology or Medicine in 1951 for this work. Since then, approximately 850 million doses of 17D vaccines have been administered worldwide. YF-Vax continues to use this proven 17D-204 substrain, cultured in avian leukosis-free chicken embryos.

How YF-Vax Trains Your Immune System: Step by Step

Here's what happens in your body after you receive the injection:

Injection and initial replication: The 0.5 mL subcutaneous injection delivers attenuated virus particles into the tissue under your skin. The virus begins to infect cells in the dermis and nearby subcutaneous tissues.

Limited viral spread: The attenuated virus replicates locally and spreads in a limited, controlled way. In healthy individuals, it doesn't spread to the liver or cause the organ damage associated with wild-type yellow fever.

Antigen presentation: Immune cells (dendritic cells) capture viral antigens from the infection site and carry them to lymph nodes, where they present them to T cells and B cells.

Antibody production: B cells produce neutralizing antibodies against the virus's structural proteins. These antibodies can bind to and neutralize the wild-type yellow fever virus in future exposures.

Memory cell formation: Long-lived memory B cells and T cells are generated. These cells persist for decades — and in most people, for life — ready to mount a rapid protective response if you're ever exposed to the real virus.

When Does Immunity Begin After YF-Vax?

Most people develop protective antibodies within 10 days of vaccination. This is why the International Certificate of Vaccination or Prophylaxis (ICVP) — your official vaccination record for yellow fever — does not become valid until 10 days after the injection. In clinical studies, seroconversion rates reached 97–100% in most U.S. vaccine recipients.

Why Does One Dose Last a Lifetime?

The robustness and longevity of the immune response to YF-Vax is exceptional. Because the 17D strain replicates in your body (unlike inactivated vaccines), it provides a strong, sustained immune stimulus similar to natural infection. Decades of epidemiological data and post-vaccination antibody studies have confirmed that a single dose provides protection lasting at least 30–35 years and likely lifelong for most healthy adults.

Want to learn more? Read what is YF-Vax and who needs it and YF-Vax side effects.

Frequently Asked Questions

Most people develop protective neutralizing antibodies within 10 days of receiving YF-Vax. The seroconversion rate is 97–100% in clinical studies of healthy adults. The International Certificate of Vaccination (ICVP) becomes valid 10 days after vaccination, reflecting this protection timeline.

YF-Vax uses a live-attenuated virus that replicates in the body, generating an immune response similar to natural infection. This produces a strong, durable humoral response with long-lived memory cells. Decades of data show this single exposure provides lifelong protection for most healthy people — a property shared by other live-attenuated vaccines like MMR and varicella.

Because YF-Vax contains a live (though attenuated) virus, people with severe immunodeficiency cannot safely mount a controlled immune response. In severely immunocompromised individuals, the attenuated virus may replicate uncontrollably, potentially causing YEL-AVD (a life-threatening viscerotropic disease). This is why the vaccine is absolutely contraindicated in people with AIDS, certain thymus disorders, or those on immunosuppressive therapy.

The 17D strain was developed in the 1930s by Max Theiler by progressively weakening the virulent Asibi strain of yellow fever through serial passage in chicken embryos. Two substrains — 17D-204 (used in YF-Vax) and 17DD — were derived in parallel and are considered immunologically equivalent. Approximately 850 million doses of 17D vaccines have been administered globally. Theiler received the Nobel Prize for this work in 1951.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for YF-Vax also looked for:

Stamaril

32,136 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,136 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?